Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ASA Gold and Precious Metals Ltd C.ASA


Primary Symbol: ASA

ASA Gold and Precious Metals Limited is a non-diversified, closed-end investment company. The Company's investment objective is long-term capital appreciation primarily through investing in companies engaged in the exploration for, development of projects or mining of precious metals and minerals. The Company invests approximately 80% of its total assets in common shares or securities convertible into common shares of companies engaged, directly or indirectly, in the exploration, mining or processing of gold, silver, platinum, diamonds or other precious minerals; held as bullion or other direct forms of gold, silver, platinum or other precious minerals; in instruments representing interests in gold, silver, platinum or other precious minerals, and/or in securities of investment companies, including exchange traded funds, or other securities. The Company’s investment adviser is Merk Investments LLC.


NYSE:ASA - Post by User

Comment by Digby8on Jul 13, 2020 7:37am
154 Views
Post# 31259116

RE:NEWS OUT 🌿

RE:NEWS OUT 🌿

This is one of the things I've been waiting to hear. Feedback from patients will allow Valens and their partners to fine tune medicinals on a compound-by-compound basis using the full universe of ingredients in cannabis. This will fundamentally advance the use of medicinal cannabis.

Excerpts:
The Valens Company has contributed to the study with the inclusion ofNuance, its exclusive brand of premium cannabis oil developed by the Company for Medical Cannabis by Shoppers. As part of the study, the Nuance line of THC and CBD oils will be tested, with the verified results on each batch made available through the Medical Cannabis by Shoppers portal for each physician and patient. Patients will be able to identify the contents of their product through the platform, including potency levels of THC and CBD, and confidently rely on the data to ensure batch-to-batch consistency and quality. The goal of this study is to provide physicians, pharmacists, and patients with confidence in medicinal cannabis products as an alternate treatment for various ailments, including pain relief.

"Nuance oils are developed exclusively for Shoppers Drug Mart with medical cannabis patients at the core. To be able to participate in this real-world study and have the opportunity to understand how our products could be used as a treatment is an exciting step in the right direction for us," said Tyler Robson, Chief Executive Officer of The Valens Company. "With insights and data from this study, we look forward to further advancing our commitment to developing and testing the highest-quality and most reliable products for patients using cannabis for both medical purposes as well as recreational consumers."

"Medical Cannabis by Shoppers is best placed to offer Canadians the reassurance of medical products that have been tested and validated," said Ken Weisbrod, Vice President, Business Development/Cannabis Strategy, Shoppers Drug Mart. "Our development of a blockchain secured initiative with TruTrace has now been integrated into an operational portal that will provide products with an immutable digital identity that can capture everything from detailed chemistry down to its DNA."

<< Previous
Bullboard Posts
Next >>